Effect of Unani Medicine for the Management of Anomalies Associated With Polycystic Ovarian Syndrome
- Registration Number
- NCT06199544
- Lead Sponsor
- Hamdard University
- Brief Summary
Currently available medications for PCOS are symptom(s) oriented but have limitations because of its complex pathophysiology. The most preferred drug against PCOS is metformin which act as an insulin sensitizer to improve insulin-glucose metabolism and anovulatory cycles in PCOS. However, its use is associated with various side effects such as bloating, diarrhea and nausea. Thus, it is imperative to explore various other alternatives to combat this gynecological problem.
- Detailed Description
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in reproductive age women, with a prevalence between 5%-15%. Currently, sedentary lifestyle, excessive intake of junk food and increasing prevalence of obesity has been associated with rise in the incidence of PCOS.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 150
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Rasoline Metformin Rasoline 500mg thrice a day Picolin group Metformin Picolin 500mg thrice a day Control group Metformin metformin 500 mg twice a day
- Primary Outcome Measures
Name Time Method Improvement in the menstrual regularity of the patient 1 year The lengths and duration of menstrual cycle of patients will be measured
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Shifa ul mulk memorial hospital
🇵🇰Karachi, Sindh, Pakistan